← All State Street CORP filings

State Street CORP Schedule 13G passive stakes

NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Arcutis Biotherapeutics Stake
State Street Corporation has updated its beneficial ownership filing for Arcutis Biotherapeutics Inc., reporting a significant holding of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.4% Stake in Archer Aviation
State Street Corporation has reported beneficial ownership of 6.4% of Archer Aviation Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 6% Stake in Annvon Inc.
State Street Corporation has disclosed beneficial ownership of 6% of Annvon Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.2% Stake in Ameris Bancorp
State Street Corporation has disclosed beneficial ownership of 5.2% of Ameris Bancorp's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Reports Stake in American Healthcare REIT
State Street Corporation has updated its beneficial ownership filing for American Healthcare REIT Inc., reporting a 4.3% stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.8% Stake in Ambarella
State Street Corporation has disclosed beneficial ownership of 5.8% of Ambarella Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 7.7% Stake in Alpha Metallurgical
State Street Corporation and SSGA Funds Management, Inc. have reported beneficial ownership of 7.7% of Alpha Metallurgical Resources Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Alpha & Omega Semiconductor
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported a combined beneficial ownership of 7.8% in Alpha & Omega Semiconductor Ltd.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Stake in Allogene Therapeutics
State Street Corporation has updated its beneficial ownership filing for Allogene Therapeutics Inc., reporting a 5.5% stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.1% Stake in Allegion PLC
State Street Corporation has disclosed a beneficial ownership of 5.1% in Allegion PLC as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.2% Stake in Adobe
State Street Corporation has disclosed beneficial ownership of 5.2% of Adobe Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Stake in ADMA Biologics
State Street Corporation and SSGA Funds Management, Inc. have updated their beneficial ownership filing for ADMA Biologics Inc., reporting a combined 7.4% stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.3% Stake in Acadia Realty Trust
State Street Corporation has disclosed beneficial ownership of 5.3% of Acadia Realty Trust's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Adjusts Stake in Acadia Pharmaceuticals
State Street Corporation has updated its beneficial ownership filing for Acadia Pharmaceuticals Inc., reporting a significant holding of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Astronix Corp
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of 10.4% and 7.4% respectively of Astronix Corp's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in World Kinect Corp
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of 7.8% and 5% respectively of World Kinect Corp's common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Williams-Sonoma Stake
State Street Corporation has reported a 4.9% beneficial ownership in Williams-Sonoma Inc. as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.7% Stake in VSE Corp
State Street Corporation has reported a beneficial ownership of 6.7% in VSE Corp, holding 1,875,026 shares as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.6% Stake in Virtus Investment Partners
State Street Corporation has reported beneficial ownership of 6.6% of Virtus Investment Partners Inc. common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Veracyte Stake
State Street Corporation has reported beneficial ownership of 6.3% of Veracyte Inc.'s common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Vanda Pharmaceuticals
State Street Corporation has reported beneficial ownership of 5.1% of Vanda Pharmaceuticals Inc. common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.6% Stake in V2X Inc.
State Street Corporation has reported beneficial ownership of 5.6% of V2X Inc.'s common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.5% Stake in USA Rare Earth
State Street Corporation has reported beneficial ownership of 5.5% of USA Rare Earth Inc.'s common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: UR-ENERGY INC: State Street Discloses 5.5% Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of 5.5% of UR-Energy Inc.'s common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Uranium Energy Corp
State Street Corporation has reported beneficial ownership of 5.1% of Uranium Energy Corp's common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in United Community Banks
State Street Corporation has reported beneficial ownership of 5.2% of United Community Banks Inc./GA's common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 3.6% Stake in Uniqure NV
State Street Corporation has reported beneficial ownership of 3.6% of Uniqure NV's common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Ultragenyx
State Street Corporation has reported beneficial ownership of 5.1% of Ultragenyx Pharmaceutical Inc.'s common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Tyson Foods Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.1% of Tyson Foods Inc. common stock as of March 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Trustmark Corp
State Street Corporation has reported beneficial ownership of 5.1% of Trustmark Corp's common stock as of March 31, 2026.